These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Ranibizumab (Lucentis) for macular degeneration. Med Lett Drugs Ther; 2006 Oct; 48(1246):85-6. PubMed ID: 17051134 [No Abstract] [Full Text] [Related]
23. Age related macular degeneration. Arnold J; Sarks S Clin Evid; 2002 Dec; (8):614-28. PubMed ID: 12603902 [No Abstract] [Full Text] [Related]
24. Clinical experience with interferon alfa-2a for exudative age-related macular degeneration. Kirkpatrick JN; Dick AD; Forrester JV Br J Ophthalmol; 1993 Dec; 77(12):766-70. PubMed ID: 7509185 [TBL] [Abstract][Full Text] [Related]
25. [Bevacizumab versus ranibizumab: a draw?]. Souied EH; Cohen SY; Kodjikian L J Fr Ophtalmol; 2012 Feb; 35(2):79-81. PubMed ID: 22033297 [No Abstract] [Full Text] [Related]
26. An update on photodynamic therapy in age-related macular degeneration. Rechtman E; Ciulla TA; Criswell MH; Pollack A; Harris A Expert Opin Pharmacother; 2002 Jul; 3(7):931-8. PubMed ID: 12083992 [TBL] [Abstract][Full Text] [Related]
27. Interferon treatment of SRNV. Donahue SP; Wall M; Weingeist TA Ophthalmology; 1994 Apr; 101(4):624-5. PubMed ID: 8152753 [No Abstract] [Full Text] [Related]
28. Visual impairment of age-related macular degeneration. An epidemiological study of 1000 aged individuals. Vinding T Acta Ophthalmol (Copenh); 1990 Apr; 68(2):162-7. PubMed ID: 2356703 [TBL] [Abstract][Full Text] [Related]
29. IFN-alpha antibodies in patients with age-related macular degeneration treated with recombinant human IFN-alpha2a. Ross C; Engler CB; Sander B; Bendtzen K J Interferon Cytokine Res; 2002 Apr; 22(4):421-6. PubMed ID: 12034024 [TBL] [Abstract][Full Text] [Related]
30. Treatment of choroidal neovascularisation in age-related macular degeneration with interferon alfa-2a and alfa-2b. Gillies MC; Sarks JP; Beaumont PE; Hunyor AB; McKay D; Kearns M; McClusky PJ; Sarks SH Br J Ophthalmol; 1993 Dec; 77(12):759-65. PubMed ID: 7509184 [TBL] [Abstract][Full Text] [Related]
31. The growing importance of pharmacoeconomics: the case of age-related macular degeneration. Smith AF Br J Ophthalmol; 2010 Sep; 94(9):1116-7. PubMed ID: 20576774 [No Abstract] [Full Text] [Related]
33. Intravitreal interferon alpha-2b for the treatment of neovascular age-related macular degeneration: a pilot study. Kertes PJ; Britton WA; Leonard BC Can J Ophthalmol; 1997 Apr; 32(3):185-8. PubMed ID: 9131284 [No Abstract] [Full Text] [Related]
39. [Epidemiology and risk factors for age related macular degeneration]. Starzycka M Klin Oczna; 1997; 99(4):271-5. PubMed ID: 9577122 [No Abstract] [Full Text] [Related]